Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — November 2025

Genmab — November 2025

Planlagt Fastgjort Låst Flyttet Genmab
176 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bb8
    wrote on sidst redigeret af
    #134

    Genmab cans another ADC from ProfoundBio deal in area of J&J's Ambrx buyout https://endpoints.news/genmab-cans-another-adc-from-profoundbio-deal-in-area-of-jjs-ambrx-buyout/ Endpoint News

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bb8
      wrote on sidst redigeret af
      #135

      Genmab sheds another clinical ADC from $1.8B ProfoundBio buy https://www.fiercebiotech.com/biotech/genmab-sheds-another-clinical-adc-18b-profoundbio-buy Fierce Biotech

      1 Reply Last reply
      0
      • R Offline
        R Offline
        Raun
        wrote on sidst redigeret af
        #136

        Er det ikke den @Sukkeralf linkede til kl. 21.21 i går aftes?

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bikube
          wrote on sidst redigeret af
          #137

          Alle de gode nyheder har så gjort, at kursen ikke er faldet ret meget i US.

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #138

            Godmorgen 🙂

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #139

              God morgen. 🙂

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #140

                Genmab Announces Pricing of Private Offering of Senior Secured Notes and Senior Unsecured Notes and Completion of Syndication of New Senior Secured Term Loan Facility https://ir.genmab.com/news-releases/news-release-details/genmab-announces-pricing-private-offering-senior-secured-notes - 6.250% senior secured notes due 2032 and 7.250% senior unsecured notes due 2033

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #141

                  Nov 19, 2025 1:00 PM CET
                  Jefferies Healthcare Conference https://ir.genmab.com/events-presentations

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    bikube
                    wrote on sidst redigeret af
                    #142

                    I hope someone listen and refere the headpoints, I can´t follow Jan´s speedtalks.

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      lahn1
                      wrote on sidst redigeret af
                      #143

                      Bikuben - download appen Quartr. Der har du alle events optaget og med transcripts og mulighed for at søge i transcripts 🙂

                      1 Reply Last reply
                      0
                      • B Offline
                        B Offline
                        bikube
                        wrote on sidst redigeret af
                        #144

                        Tak lahn de transcripts forstår jeg bedre.

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          peter12
                          wrote on sidst redigeret af
                          #145

                          Som jeg hørte det, ville de komme med to nye bi-specifikke og en ny ADC med Profound linker I år ?!
                          De regnede nu med peaksale på Rina-S på 2mia$ og at peto ville sælge for 1mia$ i 2029

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #146

                            Ja tre nye IND’er i år er ret flot - og endda BsAb-ADC.

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bikube
                              wrote on sidst redigeret af
                              #147

                              JnJ vin FDA traditional nod for Dara Faspro in AL amyloidosis. siger Seeking Alfa.

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bikube
                                wrote on sidst redigeret af
                                #148

                                Amgen får fuld FDA godkendelse for Imdelltra i SCLC. også iflg. S.A.

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bikube
                                  wrote on sidst redigeret af
                                  #149

                                  Amgen får fuld FDA godkendelse for Imdelltra i SCLC. også iflg. S.A.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #150

                                    Epkinly gets a second-line follicular nod And AbbVie and Genmab scoop their ASH presentation with new data.
                                    https://www.oncologypipeline.com/apexonco/epkinly-gets-second-line-follicular-nod

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #151

                                      Kesimpta peak salg forventes over 6 milliarder dollars:

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #152

                                        Link Preview Image
                                        Novartis venter vækst på 5-6 pct. på mellemlang sigt

                                        Novartis forventer samtidig, at salget af sklerosemidlet Kesimpta, som Genmab har del i, fortsat når et topsalg på mere end 6 mia. dollar.

                                        favicon

                                        (medwatch.dk)

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #153

                                          Virkelig flot

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper